Certainty Discovery. Frankfurt, November 4-5, 2025
Certainty Discovery 2025 review by Wendy A. Warr - Vibes, topics and key takeaways.
CertaraJanuary 29, 2026
Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)
This on demand session demonstrates how Phoenix WinNonlin® and other tools work together within Phoenix®…
CertaraJanuary 27, 2026
Chemaxon discontinues support for various file formats across product portfolio
Chemaxon discontinues support for various file formats across product portfolio in future releases.
CertaraJanuary 27, 2026
How Model-Informed Drug Development (MIDD) Strengthens Drug Asset Valuation and Answers the Questions Investors Care About Most
Learn how Model-Informed Drug Development strengthens drug asset valuation by reducing uncertainty, predicting clinical performance,…
CertaraJanuary 26, 2026
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients
This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…
CertaraJanuary 22, 2026
Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy
Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…
CertaraJanuary 22, 2026
